Harnessing Genetic Dependencies in Cancer Therapy
- đ¤ Speaker: Alan Ashworth, The Institute of Cancer Research, London
- đ Date & Time: Thursday 12 December 2013, 13:00 - 14:00
- đ Venue: Cancer Research UK Cambridge Institute, Lecture Theatre
Abstract
The design of targeted therapeutic strategies for cancer has largely been driven by the identification of tumor-specific genetic changes. However, the large number of genetic alterations present in tumor cells means that it is difficult to discriminate between genes that are critical for maintaining the disease state and those that are merely coincidental. Even when critical genes can be identified, directly targeting these is often challenging. We have exploited principles utilised for many years in model organisms to address these issues. Here I will describe particular examples of the use of synthetic lethality in cancer therapy. In addition, I will discuss high-throughput screening strategies to identify genetic dependencies in tumours.
Series This talk is part of the Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer series.
Included in Lists
- All Talks (aka the CURE list)
- Biology
- Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer
- Cancer Research UK Cambridge Institute, Lecture Theatre
- CCC talks for website
- cri
- CRUK CI Seminars
- Graduate-Seminars
- Liam
- Life Sciences
- Life Sciences
- ME Seminar
- my_list
- other talks
- PMRFPS's
- se393's list
- sfm36
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Alan Ashworth, The Institute of Cancer Research, London
Thursday 12 December 2013, 13:00-14:00